查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1381603

免疫测量市场：按类型、产品类型、应用、最终用户划分 - 全球预测 2023-2030

Radioimmunoassays Market by Type (Coated-Tube RIA, Double-Antibody RIA), Product Type (Analyzers, Reagents & Kits), Application, End-User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

免疫测量市场预计将从 2022 年的 4.3039 亿美元增至 2030 年的 6.12 亿美元，预测期内年复合成长率为 4.49%。

全球免疫测量分析市场

主要市场统计
市场金额：基准年 [2022] 43039万美元
预计市场金额[2023] 44894万美元
预计市场金额[2030]6.120亿美元 6.12 亿美元
年复合成长率（%） 4.49%
放射免疫分析市场-IMG1

FPNV定位矩阵

FPNV定位矩阵是评估免疫测量市场的重要工具。透过分析与业务策略和产品满意度相关的关键指标来全面评估供应商。这使得使用者能够根据自己的具体资讯做出明智的决策。进阶分析将供应商分为四个像限，每个象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。这个富有洞察力的框架使决策者能够充满信心地驾驭市场。

市场占有率分析

市场占有率分析为供应商的市场形势提供了宝贵的见解。评估对整体收益、客户群和其他关键指标的影响可以全面了解公司的业绩及其面临的竞争环境。该分析还揭示了研究期间的竞争水平，例如市场占有率增长、碎片化、主导地位和行业整合。

该报告对以下几个方面提供了宝贵的见解：

1.市场渗透：提供有关市场动态和主要企业产品的全面资讯。

2. 市场开拓：详细分析新兴和成熟细分市场的渗透情况，以突显利润丰厚的商机。

3. 市场多元化：有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

5. 产品开发与创新：对未来技术、研发活动和突破性产品开发的智慧洞察。

本报告解决了以下关键问题：

1.免疫测量市场的市场规模与预测为何？

2.免疫测量市场中哪些产品、细分市场、应用和领域具有最高的投资潜力？

3.免疫测量市场的竞争策略窗口是什么？

4.免疫测量市场的最新技术趋势和法律规范是什么？

5.免疫测量市场主要厂商的市场占有率是多少？

6. 进入免疫测量市场的适当型态和策略手段是什么？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 慢性疾病和感染疾病的传播
      • 全球影像中心数量不断增加
      • 快速转向早期诊断和医疗费用飙升
    • 抑制因素
      • 对放射性物质保存期限短和危险的担忧
    • 机会
      • 政府对生命科学研究活动的资助快速增加
      • 整合先进技术进行疾病诊断
    • 任务
      • 存在替代的先进免疫测量且缺乏熟练的专业人员
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第6章免疫测量市场：依类型

  • 涂层管RIA
  • 双抗体放射免疫分析

第7章免疫测量市场：依产品类型

  • 分析仪
  • 试剂和试剂盒

第8章免疫测量市场：依应用分类

  • 临床诊断
  • 调查

第9章免疫测量市场：依最终用户分类

  • 学术研究所
  • 临床诊断实验室
  • 医院
  • 製药和 CRO

第10章美洲免疫测量市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太放射免疫测量市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲免疫测量市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第14章竞争产品组合

  • 主要公司简介
    • Abbexa Limited
    • Abcam Plc
    • ALPCO
    • Antigenix America, Inc.
    • Berthold Technologies GmbH & Co.KG
    • Biosynth Ltd
    • BioVendor-Laboratorni medicina as
    • Creative Biomart, Inc.
    • Danaher Corporation
    • Demeditec Diagnostics GmbH
    • Diasorine SPA
    • DRG International, Inc. by BioCheck Inc.
    • Drive DeVilbiss International
    • EUROIMMUN Medizinische Labordiagnostika AG
    • Hidex Oy.
    • IBL International GmbH
    • Immuno-Biological Laboratories, Inc.
    • Institute of Isotopes Co. Ltd.
    • LKB Instruments
    • LubioScience GmbH
    • Marin Biologic Laboratories, Inc.
    • Merck & Co, Inc
    • Montreal Biotech Inc.
    • MP Biomedicals, LLC
    • NovoLytix GmbH
    • Padyab Teb Co.
    • PerkinElmer Inc.
  • 主要产品系列

第15章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-C002B1C99654

The Radioimmunoassays Market is projected to reach USD 612.00 million by 2030 from USD 430.39 million in 2022, at a CAGR of 4.49% during the forecast period.

Global Radioimmunoassays Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 430.39 million
Estimated Year Value [2023] USD 448.94 million
Forecast Year Value [2030] USD 612.00 million
CAGR (%) 4.49%
Radioimmunoassays Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Radioimmunoassays Market.

Based on Type, market is studied across Coated-Tube RIA and Double-Antibody RIA. The Double-Antibody RIA is projected to witness significant market share during forecast period.

Based on Product Type, market is studied across Analyzers and Reagents & Kits. The Reagents & Kits is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical Diagnostics and Research. The Research is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, Clinical Diagnostic Laboratories, Hospitals, and Pharmaceuticals & CROs. The Academic & Research Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Radioimmunoassays Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Radioimmunoassays Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Radioimmunoassays Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam Plc, ALPCO, Antigenix America, Inc., Berthold Technologies GmbH & Co.KG, Biosynth Ltd, BioVendor - Laboratorni medicina a.s., Creative Biomart, Inc., Danaher Corporation, Demeditec Diagnostics GmbH, Diasorine S.P.A., DRG International, Inc. by BioCheck Inc., Drive DeVilbiss International, EUROIMMUN Medizinische Labordiagnostika AG, Hidex Oy., IBL International GmbH, Immuno-Biological Laboratories, Inc., Institute of Isotopes Co. Ltd., LKB Instruments, LubioScience GmbH, Marin Biologic Laboratories, Inc., Merck & Co, Inc, Montreal Biotech Inc., MP Biomedicals, LLC, NovoLytix GmbH, Padyab Teb Co., and PerkinElmer Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Radioimmunoassays Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Radioimmunoassays Market?

3. What is the competitive strategic window for identifying opportunities in the Radioimmunoassays Market?

4. What are the latest technology trends and regulatory frameworks in the Radioimmunoassays Market?

5. What is the market share of the leading vendors in the Radioimmunoassays Market?

6. Which modes and strategic moves are suitable for entering the Radioimmunoassays Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Radioimmunoassays Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic and infectious disease
      • 5.1.1.2. Increasing number of imaging centers across the globe
      • 5.1.1.3. Rapid shift towards early diagnosis and surge in healthcare expenditure
    • 5.1.2. Restraints
      • 5.1.2.1. Short shelf life and associated hazards concern with radioactive materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in government funding for life science research activity
      • 5.1.3.2. Integration of advanced technology for disease diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative advanced immunoassays and the dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Radioimmunoassays Market, by Type

  • 6.1. Introduction
  • 6.2. Coated-Tube RIA
  • 6.3. Double-Antibody RIA

7. Radioimmunoassays Market, by Product Type

  • 7.1. Introduction
  • 7.2. Analyzers
  • 7.3. Reagents & Kits

8. Radioimmunoassays Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Diagnostics
  • 8.3. Research

9. Radioimmunoassays Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Clinical Diagnostic Laboratories
  • 9.4. Hospitals
  • 9.5. Pharmaceuticals & CROs

10. Americas Radioimmunoassays Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Radioimmunoassays Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Radioimmunoassays Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbexa Limited
    • 14.1.2. Abcam Plc
    • 14.1.3. ALPCO
    • 14.1.4. Antigenix America, Inc.
    • 14.1.5. Berthold Technologies GmbH & Co.KG
    • 14.1.6. Biosynth Ltd
    • 14.1.7. BioVendor - Laboratorni medicina a.s.
    • 14.1.8. Creative Biomart, Inc.
    • 14.1.9. Danaher Corporation
    • 14.1.10. Demeditec Diagnostics GmbH
    • 14.1.11. Diasorine S.P.A.
    • 14.1.12. DRG International, Inc. by BioCheck Inc.
    • 14.1.13. Drive DeVilbiss International
    • 14.1.14. EUROIMMUN Medizinische Labordiagnostika AG
    • 14.1.15. Hidex Oy.
    • 14.1.16. IBL International GmbH
    • 14.1.17. Immuno-Biological Laboratories, Inc.
    • 14.1.18. Institute of Isotopes Co. Ltd.
    • 14.1.19. LKB Instruments
    • 14.1.20. LubioScience GmbH
    • 14.1.21. Marin Biologic Laboratories, Inc.
    • 14.1.22. Merck & Co, Inc
    • 14.1.23. Montreal Biotech Inc.
    • 14.1.24. MP Biomedicals, LLC
    • 14.1.25. NovoLytix GmbH
    • 14.1.26. Padyab Teb Co.
    • 14.1.27. PerkinElmer Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. RADIOIMMUNOASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. RADIOIMMUNOASSAYS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. RADIOIMMUNOASSAYS MARKET DYNAMICS
  • FIGURE 7. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 10. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. RADIOIMMUNOASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. RADIOIMMUNOASSAYS MARKET SIZE, BY COATED-TUBE RIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. RADIOIMMUNOASSAYS MARKET SIZE, BY DOUBLE-ANTIBODY RIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. RADIOIMMUNOASSAYS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICALS & CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 188. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 189. RADIOIMMUNOASSAYS MARKET LICENSE & PRICING